Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Accumulated Expenses (2018 - 2019)

Historic Other Accumulated Expenses for Arcturus Therapeutics Holdings (ARCT) over the last 2 years, with Q3 2019 value amounting to $560000.0.

  • Arcturus Therapeutics Holdings' Other Accumulated Expenses changed N/A to $560000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $560000.0, marking a year-over-year change of. This contributed to the annual value of $674000.0 for FY2018, which is N/A changed from last year.
  • As of Q3 2019, Arcturus Therapeutics Holdings' Other Accumulated Expenses stood at $560000.0.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Other Accumulated Expenses peaked at $1.3 million during Q2 2019, and registered a low of $560000.0 during Q3 2019.